Clinical Trial Supply Chain Intelligence to Improve Forecasting, Drug Availability & Operational Efficiency

A global clinical trial technology provider faced deep fragmentation across clinical supply, site, financial, and operational systems, resulting in no single source of truth across global studies. Limited end-to-end visibility into supply demand, site consumption, enrollment trends, and budget performance reduced forecasting accuracy and slowed decision-making. Manual processes and disconnected tools increased operational inefficiencies, creating risks of stock-outs, over-shipments, delayed study progression, and inconsistent drug availability across sites.

To overcome these challenges, the organization partnered with NextGen Invent to build a next-generation Clinical Trial Supply Chain Intelligence Platform powered by a Unified Global Clinical Data Fabric. By integrating supply, site, financial, and operational data, we established governed real-time visibility, predictive forecasting, and automated drug allocation. Intelligent workflows integrated with IRT, eCOA, and CTMS reduced manual effort and enabled proactive supply management. The platform now supports optimized planning, compliant oversight, faster study startups, and reliable drug continuity across global clinical programs.

Technology Used: Generative AI, Agentic AI, Ambient AI, React (Next.js), Python (Django), PostgreSQL, Kafka, Redis, Speech-to-Text (ASR), EMR API Integrations, HIPAA-Compliant Cloud Infrastructure

The client is a global clinical trial technology provider focused on simplifying the complexities of global studies across patient management, clinical supplies, drug accountability, and eClinical data. Their configurable platform helps CROs achieve faster trial startup, streamlined operations, improved drug availability, and higher quality standards throughout the study lifecycle. With a focus on efficiency, certainty, and a better patient-site experience, the client equips clinical leaders with technology and best-practice strategies to execute studies with confidence and speed.

Better Patient-Site Matching
Improved Forecasting Accuracy & Decision Intelligence

Industry

Healthcare

Business Problem

  • No Single Source of Truth: Disconnected clinical supply, site, financial, and operational data across global sites, resulting in fragmented decision-making and a lack of a unified data foundation.
  • Limited End-to-End Visibility: Inability to seamlessly track supply demand, site consumption, enrollment trends, and budget performance across studies.
  • High Manual Effort & Inefficient Processes: Lack of unified insights hindered accurate forecasting, timely drug availability, and proactive decision-making.

Solution Approach

  • Unified Global Clinical Data Fabric: Our team established a governed single source of truth by integrating clinical supply, site, financial, and operational data across global studies.
  • End-to-End Visibility & Predictive Planning: Enabled real-time tracking of demand, site consumption, enrollment trends, and budget through predictive forecasting and automated drug allocation.
  • Automation & Intelligent Workflows: Reduced manual effort with integrated systems (IRT, eCOA, CTMS), exception-based alerts, and proactive supply management to ensure timely drug availability.

Value Delivered

The Unified Clinical Trial Supply Chain Intelligence Platform delivered a transformative shift in how life sciences organizations orchestrate clinical supplies across global studies. By harmonizing fragmented data and creating a single source of truth, the platform enabled better patient-site matching, optimized supply planning, and timely study progression. Clinical teams moved from reactive coordination to proactive, insight-led execution, minimizing delays, preventing stockouts, and ensuring uninterrupted drug availability across sites.

With real-time analytics and enhanced forecasting accuracy, sponsors and CROs gained stronger decision intelligence to anticipate demand fluctuations, align inventory with enrollment patterns, and accelerate dosing timelines. Unified data visibility empowered faster oversight, standardized workflows, and compliant operations across regions, improving governance while reducing operational risk. Built on a scalable, integration-ready architecture, the solution positions the client as a next-generation leader in Clinical Supply Chain Intelligence, driving faster study startup, greater operational agility, and reliable drug continuity across traditional, decentralized, adaptive, and emerging trial models, while elevating overall patient experience and trial performance.

Our Case Study

Stay In the Know

Get Latest updates and industry insights every month